Alexander N Meleshko (Alexander Meleshko)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Escherichia Coli

Inflammatory Response

Top Venues

Cancer immunology, immunotherapy : CII

Science advances

Belarusian State University (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Belarusian State University Sep 01 1997 - May 25 2001

Belarus

BSC :: Biological

Publications

Mikalai Katsin, Dmitri Dormeshkin, Alexander N Meleshko, Alexandr A Migas, Simon Dubovik, Natalya Konoplya
CAR-T Cell Therapy for Classical Hodgkin Lymphoma. HemaSphere 7 (12) (2023)
Alexander N Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich, Dzmitry Lutskovich, Chuan Wang, Dmitri Dormeshkin, Natalia Savelyeva, Mikalai Katsin
Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study. Cancers 14 (14) (2022)
Maria V Stegantseva, Veronika A Shinkevich, Elena M Tumar, Alexander N Meleshko
Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model. Cancer immunology, immunotherapy : CII 69 (12) (2020)
Alexey V Stepanov, Oleg V Markov, Ivan V Chernikov, Daniil V Gladkikh, Hongkai Zhang, Teresa Jones, Alexandra V Sen'kova, Elena L Chernolovskaya, Marina A Zenkova, Roman S Kalinin, Maria P Rubtsova, Alexander N Meleshko, Dmitry D Genkin, Alexey A Belogurov, Jia Xie, Alexander G Gabibov, Richard A Lerner
Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma. Science advances 4 (11) (2018)